NO870984D0 - 3,5-DISUBSTITUTED PYROCATIC COLD DERIVATIVES. - Google Patents

3,5-DISUBSTITUTED PYROCATIC COLD DERIVATIVES.

Info

Publication number
NO870984D0
NO870984D0 NO870984A NO870984A NO870984D0 NO 870984 D0 NO870984 D0 NO 870984D0 NO 870984 A NO870984 A NO 870984A NO 870984 A NO870984 A NO 870984A NO 870984 D0 NO870984 D0 NO 870984D0
Authority
NO
Norway
Prior art keywords
pyrocatic
disubstituted
derivatives
cold
cold derivatives
Prior art date
Application number
NO870984A
Other languages
Norwegian (no)
Other versions
NO165959C (en
NO870984L (en
NO165959B (en
Inventor
Karl Bernauer
Janos Borgulya
Hans Bruderer
Mose Da Prada
Gerhard Zuercher
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO870984D0 publication Critical patent/NO870984D0/en
Publication of NO870984L publication Critical patent/NO870984L/en
Publication of NO165959B publication Critical patent/NO165959B/en
Publication of NO165959C publication Critical patent/NO165959C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06—Preparation of nitro compounds
    • C07C201/08—Preparation of nitro compounds by substitution of hydrogen atoms by nitro groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C07C45/298—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with manganese derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • C07C45/305—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation with halogenochromate reagents, e.g. pyridinium chlorochromate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/56—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing hydroxy groups
    • C07C47/565—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing hydroxy groups all hydroxy groups bound to the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C07C49/83—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/017—Esters of hydroxy compounds having the esterified hydroxy group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
NO870984A 1986-03-11 1987-03-10 ANALOGY PROCEDURE FOR THE PREPARATION OF 3,5-DISUBSTITUTED PYROCATIC COLD DERIVATIVES. NO165959C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH98086 1986-03-11
CH6287 1987-01-09

Publications (4)

Publication Number Publication Date
NO870984D0 true NO870984D0 (en) 1987-03-10
NO870984L NO870984L (en) 1987-09-14
NO165959B NO165959B (en) 1991-01-28
NO165959C NO165959C (en) 1991-05-08

Family

ID=25683401

Family Applications (2)

Application Number Title Priority Date Filing Date
NO870984A NO165959C (en) 1986-03-11 1987-03-10 ANALOGY PROCEDURE FOR THE PREPARATION OF 3,5-DISUBSTITUTED PYROCATIC COLD DERIVATIVES.
NO1998006C NO1998006I1 (en) 1986-03-11 1998-01-28 Tolcapone

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO1998006C NO1998006I1 (en) 1986-03-11 1998-01-28 Tolcapone

Country Status (22)

Country Link
EP (1) EP0237929B1 (en)
JP (1) JPH0742254B2 (en)
AR (1) AR245097A1 (en)
AT (1) ATE90072T1 (en)
AU (1) AU603788B2 (en)
CA (1) CA1302418C (en)
CS (1) CS402291A3 (en)
DE (1) DE3786026D1 (en)
DK (1) DK175069B1 (en)
ES (1) ES2056792T3 (en)
FI (1) FI91396C (en)
HK (1) HK165896A (en)
HU (1) HU201900B (en)
IE (1) IE61316B1 (en)
IL (1) IL81791A (en)
LU (1) LU90219I2 (en)
LV (1) LV5742B4 (en)
MC (1) MC1807A1 (en)
NL (1) NL970041I1 (en)
NO (2) NO165959C (en)
NZ (1) NZ219496A (en)
PT (1) PT84449B (en)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI864875A0 (en) * 1986-11-28 1986-11-28 Orion Yhtymae Oy NYA FARMAKOLOGISKT AKTIVA FOERENINGAR, DESSA INNEHAOLLANDE KOMPOSITIONER SAMT FOERFARANDE OCH MELLANPRODUKTER FOER ANVAENDNING VID FRAMSTAELLNING AV DESSA.
YU213587A (en) * 1986-11-28 1989-06-30 Orion Yhtymae Oy Process for obtaining new pharmacologic active cateholic derivatives
US5283352A (en) * 1986-11-28 1994-02-01 Orion-Yhtyma Oy Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same
US5489614A (en) * 1987-11-27 1996-02-06 Orion-Yhtyma Oy Catechol derivatives, their physiologically acceptable salts, esters and use
MTP1031B (en) * 1987-12-24 1990-10-04 Orion Yhtymae Oy New use of cathecol-o-methyl transferase (comt) inhibitors and their physiologically acceptable salts and esters
GB9113431D0 (en) * 1991-06-20 1991-08-07 Orion Yhytma Oy Method for the preparation of 3,4-dihydroxy-5-nitrobenzaldehyde
GB9419274D0 (en) * 1994-09-23 1994-11-09 Orion Yhtymae Oy New method for the preparation of 3,4-dihydroxy-5-nitrobenzaldehyde
GB9626472D0 (en) 1996-12-20 1997-02-05 Aperia Anita C New use of comt inhibitors
ID19540A (en) * 1997-01-22 1998-07-23 Hoffmann La Roche METHOD OF MAKING BENZOFENON DECREASES
GB9819382D0 (en) * 1998-09-04 1998-10-28 Cerebrus Ltd Chemical compounds I
GB2344819A (en) * 1998-12-18 2000-06-21 Portela & Ca Sa 2-Phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones
DE19960105A1 (en) * 1999-12-14 2001-06-21 Haarmann & Reimer Gmbh Catechol oximes and their use in cosmetic and dermatological preparations
FI20000635A0 (en) * 2000-03-17 2000-03-17 Orion Yhtymae Oyj Use of COMT inhibitors as an analgesic
AU2001256765A1 (en) * 2000-05-16 2001-11-26 Nippon Soda Co., Ltd. Phenyloxazole compounds and fungicides for agricultural and horticultural use
GB0015228D0 (en) * 2000-06-21 2000-08-16 Portela & Ca Sa Substituted nitrated catechols, their use in the treatment of some central and peripheral nervous system disorders
GB2363792A (en) * 2000-06-21 2002-01-09 Portela & Ca Sa Nitrocatechols
FI20012242A0 (en) * 2001-11-19 2001-11-19 Orion Corp New pharmaceutical compounds
WO2004100929A1 (en) 2003-05-12 2004-11-25 Synergia Pharma, Inc. Threo-dops controlled release formulation
US8158149B2 (en) 2004-05-12 2012-04-17 Chelsea Therapeutics, Inc. Threo-DOPS controlled release formulation
US8273383B2 (en) 2004-05-04 2012-09-25 Children's Medical Center Corporation Methods and compositions for treatment of preeclampsia
DE102004023332A1 (en) * 2004-05-12 2006-01-19 Bayer Cropscience Gmbh Quinoxaline-2-one derivatives, crop protection agents containing them, and processes for their preparation and their use
US20060173074A1 (en) 2004-11-10 2006-08-03 Juha Ellmen Treatment of restless legs syndrome
PL1907382T3 (en) 2005-07-26 2016-01-29 Bial Portela & Ca Sa Nitrocatechol derivatives as comt inhibitors
EP1845097A1 (en) * 2006-04-10 2007-10-17 Portela & Ca., S.A. Oxadiazole derivatives as COMT inhibitors
WO2008003028A2 (en) 2006-06-28 2008-01-03 Chelsea Therapeutics, Inc. Pharmaceutical compositions comprising droxidopa
EP2099933A4 (en) 2006-11-21 2010-03-24 Beth Israel Hospital PROTEINS AND GENES ASSOCIATED WITH HYPOXIA AND FOR THE DIAGNOSIS AND TREATMENT OF PREGNANCY COMPLICATIONS
BRPI0721213B1 (en) 2007-01-31 2021-11-09 Bial - Portela & Ca, S.A. USE OF REPLACED NITROCATECOLS, AND PACKAGING
ES2500053T3 (en) 2007-03-09 2014-09-29 Chelsea Therapeutics, Inc. Pharmaceutical composition comprising droxidopa for the treatment of fibromyalgia
JP2010526820A (en) 2007-05-07 2010-08-05 チェルシー・セラピューティクス，インコーポレイテッド Droxidopa and pharmaceutical composition thereof for treating mood disorder, sleep disorder, or attention deficit disorder
JP2009126784A (en) * 2007-11-19 2009-06-11 Mitsubishi Gas Chem Co Inc A method for producing 2-iodo-3,4-dimethoxybenzonitrile.
US7923462B2 (en) * 2007-12-25 2011-04-12 Kissei Pharmaceutical Co., Ltd. Catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition
WO2009116882A1 (en) 2008-03-17 2009-09-24 Portela & Ca., S.A. Crystal forms of 5- [3- (2, 5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl) [1,2,3] oxadiazol-5-yl] -3-nit robenzene-1, 2-diol
ES2402562T3 (en) 2008-07-04 2013-05-06 Kissei Pharmaceutical Co., Ltd. Catechol derivative and its use
PT2413912T (en) 2009-04-01 2019-06-11 Bial Portela & Ca Sa Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof
JP5707063B2 (en) * 2009-06-18 2015-04-22 キッセイ薬品工業株式会社 Novel catechol derivatives, pharmaceutical compositions containing them, and uses thereof
JP5529639B2 (en) * 2009-06-18 2014-06-25 キッセイ薬品工業株式会社 Novel catechol-O-methyltransferase inhibitor
EA026419B1 (en) 2010-03-04 2017-04-28 Орион Корпорейшн APPLICATION OF LEVODOPA, CARBIDOPE AND ENTACAPON TO TREAT PARKINSON'S DISEASE
US20140045900A1 (en) 2011-02-11 2014-02-13 Bial-Portela & Ca, S.A. Administration regime for nitrocatechols
JP5880913B2 (en) 2011-05-17 2016-03-09 三郎 佐古田 Treatment for trunk symptoms (postural reflex abnormalities) in Parkinson's disease
JP6456143B2 (en) 2011-12-13 2019-01-23 ノヴィファーマ，エス．アー． Chemical compounds useful as intermediates for preparing catechol-O-methyltransferase inhibitors
CA2863585A1 (en) 2012-01-31 2013-08-08 Lundbeck Na Ltd. Improving postural stability administering droxidopa
US9109005B2 (en) * 2012-02-23 2015-08-18 Boehringer Ingelheim International Gmbh Method for manufacturing of ciclesonide
TWI638802B (en) * 2012-05-24 2018-10-21 芬蘭商奧利安公司 Catechol o-methyltransferase activity inhibiting compounds
WO2014147464A2 (en) * 2013-03-20 2014-09-25 Ra Chem Pharma Limited Novel process for the preparation of tolcapone
RU2017120184A (en) 2014-11-28 2018-12-28 БИАЛ - ПОРТЕЛА ЭНД Ка, С.А. DRUGS TO DELAY THE COURSE OF PARKINSON'S DISEASE
ES2913051T3 (en) 2015-12-24 2022-05-31 Univ California CFTR Regulators and Methods of Using Them
JP2020158391A (en) * 2017-06-13 2020-10-01 株式会社富士薬品 Novel nitrocatechol derivative
US11872236B2 (en) 2018-04-05 2024-01-16 Calasia Pharmaceuticals, Inc. Pharmacological agents for treating ocular diseases
WO2022150962A1 (en) * 2021-01-12 2022-07-21 Westlake Pharmaceutical (Hangzhou) Co., Ltd. Protease inhibitors, preparation, and uses thereof
CN114560771B (en) * 2022-03-07 2023-10-27 中北大学 Method for photocatalytic selective nitration of bromophenol
WO2025016521A1 (en) 2023-07-18 2025-01-23 Universitat Autonoma De Barcelona Compound for the treatment of transthyretin amyloidosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54128542A (en) * 1978-03-27 1979-10-05 Ube Ind Ltd Preparation of 3-cyanocatechol derivative
GB2038819B (en) * 1978-12-21 1983-02-16 Secr Defence Initiatory explosives comprising a lead salt of 3,5-dinitro-catechol
EP0375668A3 (en) * 1983-10-25 1990-10-17 FISONS plc Phenylethylamines, process for their preparation and compositions containing them
DE3406329A1 (en) * 1984-02-22 1985-08-22 Merck Patent Gmbh, 6100 Darmstadt PYRIDONE
CA1339860C (en) * 1985-06-17 1998-05-12 Tsunehiko Soga Derivatives of penem

Also Published As

Publication number Publication date
CS402291A3 (en) 1992-12-16
DK82087A (en) 1987-09-12
NL970041I1 (en) 1998-02-02
FI91396C (en) 1994-06-27
LV5742A4 (en) 1996-10-20
IE870609L (en) 1987-09-11
JPS62240649A (en) 1987-10-21
HU201900B (en) 1991-01-28
IE61316B1 (en) 1994-11-02
ES2056792T3 (en) 1994-10-16
DK82087D0 (en) 1987-02-18
PT84449A (en) 1987-04-01
NO165959C (en) 1991-05-08
HK165896A (en) 1996-09-13
CA1302418C (en) 1992-06-02
MC1807A1 (en) 1987-12-22
DE3786026D1 (en) 1993-07-08
EP0237929B1 (en) 1993-06-02
ATE90072T1 (en) 1993-06-15
NO870984L (en) 1987-09-14
IL81791A (en) 1992-12-01
FI871041A0 (en) 1987-03-10
FI871041A7 (en) 1987-09-12
IL81791A0 (en) 1987-10-20
NZ219496A (en) 1990-12-21
AU603788B2 (en) 1990-11-29
HUT43804A (en) 1987-12-28
LU90219I2 (en) 1998-05-28
FI91396B (en) 1994-03-15
LV5742B4 (en) 1996-12-20
PT84449B (en) 1989-10-04
EP0237929A1 (en) 1987-09-23
NO1998006I1 (en) 1998-01-28
NO165959B (en) 1991-01-28
JPH0742254B2 (en) 1995-05-10
DK175069B1 (en) 2004-05-24
AR245097A1 (en) 1993-12-30
AU6976487A (en) 1987-09-17

Similar Documents

Publication Publication Date Title
NO870984L (en) 3,5-DISUBSTITUTED PYROCATIC COLD DERIVATIVES.
DE3783669D1 (en) ALPHA-ARYL-ALPHA-PHENETHYL-1H-1,2,4-TRIAZOL-1-PROPAN-NITRILE.
DE3763411D1 (en) 1,2,3,6-TETRAHYDRO-5-NITRO-PYRIMIDINE DERIVATIVES.
FI875619A0 (en) 6-BENZOXAZINYL-OCH 6-BENZOTIAZONYL-2,3,4,5-TETRAHYDROPYRIDAZIN-3-ONER.
FI874428A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV VINYLKLORID MEDELST TERMISK SPJAELKNING AV 1,2-DIKLORETAN.
FI871874A7 (en) FOERFARANDE FOER FRAMSTAELLNING AV 1,4-DISUBSTITUERADE PIPERAZINDERIVAT.
DE3765646D1 (en) 2,5,6,7-TETRANOR-4,8-INTER-M-PHENYLENE-PGI2 DERIVATIVES.
DE3772122D1 (en) SUBSTITUTED 1,5-BENZODIAZEPINE DERIVATIVES.
FI883266A7 (en) 4-AMINOSUBSTITUERADE 1,2-DIHYDRONAPHTHALENDER DERIVATIVES.
FI871637A7 (en) FOERFARANDE FOER FRAMSTAELLNING AV 1,5-BENZOTHIAZEPINDERIVAT.
DE3887281D1 (en) 1,2,3,4-tetrahydro-5-nitro-pyrimidine derivatives.
FI852554A7 (en) Antibacterial 7-oxo-4-thia-1-azabicyclo(3,2,0)-hept-2-ene derivatives.
DE3585315D1 (en) 5,6,7,8-TETRAFLUORANTHRACHINE DERIVATIVES.
DE3888097D1 (en) 1,2,3,4-tetrahydro-5-nitro-pyrimidine derivatives.
FI874956A7 (en) ETTSTEGSFOERFARANDE FOER FRAMSTAELLNING AV BLANDSUBSTITUERADE 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOKOLINER.
FI874413L (en) FOERFARANDE FOER FRAMSTAELLNING AV ARALKYL-4H-1,2,4-TRIAZOLDERIVAT.
DE3586745D1 (en) 9,11-EPOXY-21-HYDROXYPREGNAN DERIVATIVES.
DE3781246D1 (en) 1,5-DISUBSTITUTED IMIZADOLE.
FI875362A7 (en) FOERFARANDE FOER FRAMSTAELLNING AV N,N'-DISUBSTITUERADE CARBAMIDER.
DE58903154D1 (en) 2,2-DIFLUORCYCLOPROPYL DERIVATIVES.
FI890483A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV SULFATERADE ALKANOL- ELLER ALKYLFENOLOXETYLATER MED SAENKT 1,4-DIOXANHALT.
FI880417A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV 14,15-SUBSTITUERADE LANOSTEROLER.
FI871368L (en) FOERFARANDE FOER FRAMSTAELLNING AV 2,3,4,5-TETRAFLUORO-BENZOYLACETATER.
FI874085L (en) FOERFARANDE FOER FRAMSTAELLNING AV 2,3,5,6-TETRACHLORPYRIDIN.
FI873789L (en) 13 -ALKYLGONANE-/ 9(11)-5,10-EPOXIDE.

Legal Events

Date Code Title Description
MK1K Patent expired